The St. Louis-based center will serve as a base where researchers and public health experts can fight the HIV epidemic together.
St. Louis © Kovcs - stock.adobe.com
A new HIV research center is coming to St. Louis, thanks to a collaboration between researchers from the Washington University School of Medicine in St. Louis and Saint Louis University. The Midwest Developmental Center for AIDS Research will open in September with funding from the National Institutes of Health (NIH), making it the 20th Center for AIDS Research site in the United States, according to a Eureka Alert! news release published last week.
HIV cases and death rates in Missouri have not improved since 2017, likely due to a lack of awareness and resources. Nearly 500 people in the state are diagnosed every year and about 200 die, meaning most are diagnosed late in the disease, which makes treatment complicated since immune cells have started to die off.
In 2019, the Centers for Disease Control and Prevention (CDC) identified 220 U.S. counties at high risk for HIV. Missouri counties accounted for 13 spots on the list.
“There’s a public perception that we’re on the other side of the HIV epidemic,” Elvin Geng, MD, a Washington University professor of medicine who will direct the new center said in the news release. “St. Louis continues to have a significant HIV epidemic. One problem we face here in St. Louis is that the scientific and public health communities are strong but siloed. The goal of this center is to break down those siloes so we can all work together more effectively to end the HIV epidemic in the region.”
The center will support research at all levels, including laboratory experiments and community programs such as:
The center will also participate in the STAR (Stimulating Training and Access to HIV Research Experiences) program, a yearlong program for undergraduate and graduate students looking to become the next generation of HIV researchers.
The priority for the center is treating those in St. Louis with long-term goals to expand into the surrounding rural areas.
FDA Accepts NDA for Gilead's New HIV Prevention Shot
February 18th 2025Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving this drug a priority review and expects to make a decision by June 19, 2025, according to a release.
Read More
HIV + Hepatitis Institute Welcomes RFK, Talks Importance of Ending the HIV Epidemic
February 13th 2025The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
Read More
Trump Administration Throws U.S. AIDS Support into Turmoil
February 6th 2025PEPFAR, the main U.S.-funded global AIDS program was given a waiver from the foreign aid freeze, but there is still uncertainty and interruptions, partly because many PEPFAR programs are implemented through USAID, which has been largely shutdown by the news administration.
Read More
RFK Jr. and HIV Denial: He Says He Is Neutral, But...
January 29th 2025In 2021 book attacking Anthony Fauci, M.D., Robert F. Kennedy Jr. casts doubt on HIV being the sole cause of AIDS and presents arguments made by "HIV deniers" that believe it is bystander in the immunosuppression that characterizes AIDS.
Read More